Schedule 13G ownership disclosure

WEREWOLF THERAPEUTICS INC

Common stock, par value $0.0001 per share (the "Shares") · CUSIP: 95075A107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • PFM Health Sciences, LP

    Shares: 401,110.00 · Class: 0.9%

  • PFM Health Sciences GP, LLC

    Shares: 401,110.00 · Class: 0.9%

  • Partner Asset Management, LLC

    Shares: 401,110.00 · Class: 0.9%

  • Brian D. Grossman

    Shares: 401,110.00 · Class: 0.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-078730
Form type
SCHEDULE 13G/A
Filer
PFM Health Sciences, LP
CIK
CIK 1442756
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub